Epirubicin and hepatic failure Patient Reports February 12, 2012

Epirubicin Side Effects Report #4546344-4
Epirubicin side effect was reported by a Physician from on Dec 22, 2004. Male patient, 64 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: coma hepatic, hepatic failure, jaundice . Epirubicin dosage: 50 MG (50 MG, 1 D) INTRA-ARTERIAL. Patient was hospitalized. Patient died on 04/20/2002.

Epirubicin Side Effects Report #4563713-7
Epirubicin side effect was reported by a Physician from on Jan 13, 2005. Male patient, 64 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: coma hepatic, hepatic failure, liver disorder. Epirubicin dosage: 50 MG (50 MG, 1 D), INTRA-ARTERIAL. Patient was hospitalized. Patient died on 04/30/2002.

Epirubicin Side Effects Report #4546346-8
Epirubicin side effect was reported by a Physician from on Dec 22, 2004. Female patient, 57 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: coma hepatic, hepatic failure, jaundice , nausea . Epirubicin dosage: 50 MG (50 MG, 1 D), INTRA-ARTERIAL. Patient was hospitalized. Patient died on 08/15/2000.

Epirubicin Side Effects Report #4563710-1
Epirubicin side effect was reported by a Physician from on Jan 13, 2005. Female patient, 57 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: coma hepatic, hepatic failure, jaundice , nausea . Epirubicin dosage: 50 MG (50 MG, 1 ), INTRA-ARTERIAL. Patient was hospitalized. Patient died on 08/15/2000.


Epirubicin Side Effects Report #4546340-7
Epirubicin side effect was reported by a Physician from on Dec 22, 2004. Male patient, 52 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: duodenal ulcer haemorrhage, haematemesis, hepatic failure, hepatic neoplasm malignant, liver disorder, nausea . Epirubicin dosage: 20 MG (20 MG 1 D), INTRA-ARTERIAL. Patient was hospitalized. Patient died on 08/17/1999.

Epirubicin Side Effects Report #4565010-2
Epirubicin side effect was reported by a Physician from on Jan 13, 2005. Male patient, 52 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: duodenal ulcer haemorrhage, haematemesis, hepatic failure. Epirubicin dosage: 20 MG (20 MG, 1 D), INTRA-ARTERIAL. Patient was hospitalized. Patient died on 08/17/1999.

Epirubicin Side Effects Report #5258103-8
Epirubicin side effect was reported by a Physician from JAPAN on Feb 23, 2007. Female patient was diagnosed with breast cancer metastatic, metastases to bone and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure, hepatic failure. Epirubicin dosage: DAILY DOSE:60MG/M*2. During the same period patient was treated with FLUOROURACIL, ENDOXAN, ZOMETA, LANIRAPID, TAKEPRON, GASCON, MAGNESIUM OXIDE. Patient was hospitalized. Patient died on 01/22/2007.

Epirubicin Side Effects Report #5298325-3
Epirubicin side effect was reported by a Physician from JAPAN on Apr 04, 2007. Female patient, weighting 134.5 lb, was diagnosed with breast cancer metastatic, metastases to bone and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure, hepatic failure, pleural effusion. Epirubicin dosage: DAILY DOSE:90MG. During the same period patient was treated with FLUOROURACIL, ENDOXAN, ZOMETA, TAKEPRON, GASCON, MAGNESIUM OXIDE, LENDORMIN, MEVALOTIN. Patient was hospitalized. Patient died on 01/22/2007.

Epirubicin Side Effects Report #4607662-4
Epirubicin side effect was reported by a Health Professional from on Feb 28, 2005. Female patient, 56 years of age, weighting 134.5 lb, was diagnosed with ill-defined disorder and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: anaemia, escherichia bacteraemia, febrile bone marrow aplasia, gastrointestinal haemorrhage, hepatic failure, septic shock, shock haemorrhagic, streptococcal infection . Epirubicin dosage: 100 MG, INTRAVENOUS. During the same period patient was treated with PEGFILGRASTIM, DOCETAXEL, ERYTHROPOIETIN. Patient was hospitalized. Patient died on 01/11/2005.